JBM (Healthcare) Limited (HKG:2161)

Hong Kong · Delayed Price · Currency is HKD

1.660

+0.050 (3.11%)

Oct 30, 2026, 4:08 PM HKT

Market Cap	1.36B -43.1%
Revenue (ttm)	834.63M +6.7%
Net Income	201.09M +1.9%
EPS	0.25 +2.3%
Shares Out	819.80M
PE Ratio	6.74
Forward PE	6.31
Dividend	0.17 (10.30%)
Ex-Dividend Date	Sep 7, 2026

Volume	656,000
Open	1.625
Previous Close	1.610
Day's Range	1.625 - 1.700
52-Week Range	1.475 - 3.110
Beta	0.23
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About JBM (Healthcare)

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2020

Employees 404

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2161

Full Company Profile

Financial Performance

In fiscal year 2026, JBM (Healthcare)'s revenue was 834.63 million, an increase of 6.69% compared to the previous year's 782.29 million. Earnings were 201.09 million, an increase of 1.94%.

Financial Statements